ClinicalTrials.gg
Not yet recruitingNCT07808762FOREST-INUpdated Nov 4, 2026

Feasibility of Implementing the Internet-Delivered Stress Recovery Intervention FOREST for Healthcare Staff in a Real-World Healthcare Setting

An interventional study of FOREST in Stress (Psychology), sponsored by Vilnius University. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Vilnius University · Not applicable, Interventional, and Prevention

Updated Nov 4, 2026Start date movedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the study is to assess the feasibility of implementing the internet-delivered stress recovery intervention FOREST for healthcare staff in a real-world healthcare setting and to obtain preliminary estimates of changes in stress recovery and mental health outcomes.

Read the detailed description

The feasibility of implementing the evidence-based, internet-delivered stress recovery intervention FOREST for healthcare staff in a real-world healthcare setting will be evaluated using a single-arm pre-post study design. The study aims to assess the feasibility of implementing the intervention within a hospital setting and to obtain preliminary estimates of changes in stress recovery and mental health outcomes to inform broader implementation across healthcare settings. Information about the intervention and the study will be disseminated within participating healthcare settings. Interested healthcare staff will complete an online eligibility screening. Individuals who meet the inclusion criteria will be invited to provide informed consent and complete the baseline assessment before being enrolled in and granted access to the FOREST intervention.

The FOREST intervention consists of six sessions (Introduction, Psychological Detachment, Distancing, Mastery, Control, and Keeping the Change Alive) delivered over a four-week period. Each session includes psychoeducational content presented through text and video materials, as well as practical stress recovery exercises. Participants will also have access to support from a trained psychologist on demand throughout the intervention.

Assessments will be conducted at baseline, immediately after the four-week intervention, and at a 12-week follow-up after baseline. The study's primary outcomes will assess implementation at the individual level, guided by Proctor et al.'s Implementation Outcomes Framework to evaluate acceptability and appropriateness, alongside intervention uptake (initiation), and complemented by feasibility and process indicators capturing reach, recruitment, engagement, and retention. Secondary outcomes will provide preliminary estimates of changes in stress recovery and other mental health outcomes.

02

Conditions studied

  • Stress (Psychology)

Keywords

  • Healthcare staff
  • Stress recovery
  • Internet-delivered intervention
  • Implementation feasibility
  • FOREST
03

In context

Lead sponsor

Vilnius University is the lead sponsor of 61 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • being at least 18 years old
  • working in a healthcare setting;
  • understanding Lithuanian;
  • living in Lithuania;
  • having access to an internet-enabled device.

Exclusion Criteria: No additional exclusion criteria will be applied in order to maximize inclusiveness and reflect real-world implementation.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    Intervention group

    The intervention group will get a four-week internet-delivered stress recovery intervention FOREST.

    Behavioral: FOREST

Interventions

  • BehavioralFOREST

    The internet-delivered stress recovery intervention FOREST consists of six sessions (Introduction, Psychological Detachment, Distancing, Mastery, Control, and Keeping the Change Alive) delivered over a four-week period. Each session includes psychoeducational content presented through text and video materials, as well as practical stress recovery exercises. Participants also have access to support from a trained psychologist on demand throughout the intervention.

06

What researchers measure

Primary outcomes

  1. Reach

    Measurement: study recruitment records. Reach will be assessed as the proportion of the target healthcare workforce that enrolls in the intervention. It will be calculated as the number of enrolled participants divided by the estimated number of healthcare staff in the target workforce, expressed as a percentage.

    Time frame: Through completion of recruitment, up to 9 months.

  2. Recruitment

    Measurement: Study screening, eligibility, and informed consent records. Recruitment will be assessed as the number and proportion of eligible healthcare staff who provide informed consent and enroll in the study.

    Time frame: Through completion of recruitment, up to 9 months.

  3. Intervention uptake

    Measurement: FOREST intervention platform usage records. Intervention uptake will be assessed as the number and proportion of enrolled participants who initiate the intervention by completing the first FOREST session.

    Time frame: Through completion of the intervention period, up to 10 months.

  4. Number of intervention sessions completed

    Number of intervention sessions completed will be assessed using FOREST intervention platform usage records. The number of FOREST intervention sessions completed by each participant will be recorded.

    Time frame: Through completion of the intervention period, up to 10 months.

  5. Percentage of participants completing all six intervention sessions

    Percentage of participants completing all six FOREST intervention sessions will be assessed using FOREST intervention platform usage records. The percentage of participants who complete all six FOREST intervention sessions will be calculated as the number of participants completing all six sessions divided by the total number of participants who initiated the intervention, multiplied by 100.

    Time frame: Through completion of the intervention period, up to 10 months.

  6. Retention

    Measurement: Study assessment completion records. Retention will be assessed as the number and proportion of enrolled participants who complete the post-intervention assessment and the 12-week follow-up assessment. Unit of Measure: Number and percentage of participants completing each assessment time point.

    Time frame: Through completion of the 12-week follow-up, up to 12 months.

  7. Intervention acceptability

    Measurement: Post-intervention acceptability questions developed by study researchers. Acceptability will be assessed using post-intervention participant questions evaluating satisfaction with the FOREST intervention, perceived usefulness, and likelihood of recommending the intervention to colleagues. Each item will be reported according to its response scale, with descriptive summary statistics presented for participant responses. Higher scores indicate more pronounced acceptability.

    Time frame: Through completion of the post-intervention assessment period, up to 10 months.

  8. Intervention appropriateness

    Measurement: Post-intervention appropriateness question developed by study researchers. Appropriateness will be assessed using a post-intervention participant question evaluating participants' perceptions of whether the FOREST intervention is relevant and suitable for healthcare staff working in a hospital setting. The item will be reported according to its response scale, with descriptive summary statistics presented for participant responses. A higher score indicates more pronounced appropriateness.

    Time frame: Post-intervention assessment, up to 10 months.

Secondary outcomes

  1. Changes in stress recovery

    Changes in stress recovery are measured. The Recovery Experiences Questionnaire (Sonnentag \& Fritz, 2007) is a self-report measure consisting of 16 questions. All items are answered on a 5-point Likert scale ranging from 1 (Totally disagree) to 5 (Totally agree). A higher score indicates more pronounced stress recovery.

    Time frame: Baseline, post-test after four weeks, follow-up after 12 weeks

  2. Changes in perceived stress

    Changes in perceived stress are measured. Perceived Stress Scale (PSS-4, Cohen et al., 1983) is a self-report measure consisting of four questions. All items are answered on a 5-point Likert scale ranging from 0 (Never) to 4 (Very often). A higher score indicates more pronounced perceived stress.

    Time frame: Baseline, post-test after four weeks, follow-up after 12 weeks

  3. Changes in symptoms of anxiety and depression

    Changes in symptoms of anxiety and depression are measured. The Patient Health Questionnaire-4 (PHQ-4; Kroenke et al., 2009) is a self-report measure consisting of four questions. All items are answered on a 4-point Likert scale ranging from 0 (Not at all) to 3 (Nearly every day). A higher score indicates more pronounced symptoms of anxiety and depression.

    Time frame: Baseline, post-test after four weeks, follow-up after 12 weeks

  4. Changes in mental well-being

    Changes in mental well-being are measured. Well-being Index (WHO-5, Bech, 2004) is a self-report measure consisting of five questions. All items are answered on a 6-point Likert scale ranging from 0 (At no time) to 5 (All of the time). A higher score indicates more pronounced mental well-being.

    Time frame: Baseline, post-test after four weeks, follow-up after 12 weeks

07

Study locations

No study locations are listed for this record.

08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Start is estimated for Nov 2026; primary completion for Sep 2027, 10 months later.

Start moved once since we started tracking on Sep 25, 2026: Oct 2026 → Nov 2026, on Nov 4, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 24, 2026
First posted
Sep 9, 2026
StartEst.
Nov 2026was Oct 2026
Primary completionEst.
Sep 2027
CompletionEst.
Sep 2027
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Oct 2026→Nov 2026
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Start date Oct 2026→Nov 2026

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07808762
Lead sponsor
Vilnius University
Responsible party
Austeja Dumarkaite (Assistant professor, Vilnius University) — Principal investigator
First posted
Sep 9, 2026
Start date
Nov 2026 (estimated)
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Nov 4, 2026

Study contacts

Austeja Dumarkaite, PhD
Contact
austeja.dumarkaite@fsf.vu.lt
+37052686952
Evaldas Kazlauskas, PhD
Contact
evaldas.kazlauskas@fsf.vu.lt
+37052686952
Austeja Dumarkaite, PhD
principal investigator · Vilnius University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion